Immunotech Laboratories, Inc. (IMMB)

Immunotech Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2009
Period Ending	Dec 31, 2009
Cash & Equivalents	0
Cash & Short-Term Investments	0
Total Current Assets	0
Property, Plant & Equipment	0.41
Other Intangible Assets	10.01
Other Long-Term Assets	0.02
Total Assets	10.45
Accounts Payable	0.45
Accrued Expenses	0.51
Total Current Liabilities	0.96
Long-Term Debt	1.2
Other Long-Term Liabilities	1.55
Total Liabilities	3.7
Common Stock	6.75
Shareholders' Equity	6.75
Total Liabilities & Equity	10.45
Total Debt	1.2
Net Cash (Debt)	-1.19
Net Cash Per Share	-0.02
Filing Date Shares Outstanding	60.56
Total Common Shares Outstanding	60.56
Working Capital	-0.95
Book Value Per Share	0.11
Tangible Book Value	-3.27
Tangible Book Value Per Share	-0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.